Clues to VIP function from knockout mice

被引:18
作者
Hamidi, S. A.
Szema, A. M.
Lyubsky, S.
Dickman, K. G.
Degene, A.
Mathew, S. M.
Waschek, J. A.
Said, S. I. [1 ]
机构
[1] SUNY Stony Brook, Hlth Sci Ctr, Stony Brook, NY 11794 USA
[2] Vet Adm Med Ctr, Northport, NY 11768 USA
[3] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA
来源
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY | 2006年 / 1070卷
关键词
VIP; lung; bronchial asthma; endotoxemia; septic shock; pulmonary circulation; knockout mice;
D O I
10.1196/annals.1317.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have taken advantage of the availability of vasoactive intestinal polypeptide (VIP) knockout (KO) mice to examine the possible influence of deletion of the VIP gene on: (a) airway reactivity and airway inflammation, as indicators of bronchial asthma; (b) mortality from endotoxemia, a model of septic shock; and (c) the pulmonary circulation. VIP KO mice showed: (a) airway hyperresponsiveness to the cholinergic agonist methacholine, as well as peribronchial and perivascular inflammation; (b) a greater susceptibility to death from endotoxemia; and (c) evidence suggestive of pulmonary hypertension.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 8 条
[1]   ELEVATED VIP AND ENDOTOXIN PLASMA-LEVELS IN HUMAN GRAM-NEGATIVE SEPTIC SHOCK [J].
BRANDTZAEG, P ;
OKTEDALEN, O ;
KIERULF, P ;
OPSTAD, PK .
REGULATORY PEPTIDES, 1989, 24 (01) :37-44
[2]   Disrupted circadian rhythms in VIP- and PHI-deficient mice [J].
Colwell, CS ;
Michel, S ;
Itri, J ;
Rodriguez, W ;
Tam, J ;
Lelievre, V ;
Hu, Z ;
Liu, X ;
Waschek, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (05) :R939-R949
[3]  
Delgado M, 1999, J IMMUNOL, V162, P1200
[4]   The significance of vasoactive intestinal peptide in immunomodulation [J].
Delgado, M ;
Pozo, D ;
Ganea, D .
PHARMACOLOGICAL REVIEWS, 2004, 56 (02) :249-290
[5]   Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide [J].
Said, SI ;
Dickman, KG .
REGULATORY PEPTIDES, 2000, 93 (1-3) :21-29
[6]  
SAID SI, 1991, ANN NY ACAD SCI, V629, P305
[7]  
Tandon R, 1999, AM J RESP CRIT CARE, V159, pA612
[8]   Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide [J].
Voice, JK ;
Dorsam, G ;
Chan, RC ;
Grinninger, C ;
Kong, Y ;
Goetzl, EJ .
REGULATORY PEPTIDES, 2002, 109 (1-3) :199-208